Data as of Aug 22
| +0.0074 / +0.82%|
The 2 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.50 and a low estimate of 1.00. The median estimate represents a +37.38% increase from the last price of 0.91.
The current consensus among 2 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.